BRIEF published on 05/31/2024 at 17:03, 1 year 9 months ago Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA FDA Approval Moderna Vaccine RSV MRESVIA
BRIEF published on 05/31/2024 at 17:03, 1 year 9 months ago Moderna reçoit l'approbation de la FDA américaine pour le vaccin contre le RSV mRESVIA Approbation De La FDA Moderne VRS MRESVIA Vaccin
PRESS RELEASE published on 05/31/2024 at 16:58, 1 year 9 months ago Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R) Moderna gains FDA approval for mRESVIA, a single-dose pre-filled syringe RSV vaccine for adults 60+ to prevent lower respiratory tract disease. Second mRNA product and breakthrough therapy designation FDA Approval Moderna RSV Vaccine MRNA MRESVIA
BRIEF published on 05/22/2024 at 13:05, 1 year 9 months ago Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting Clinical Trials Immunotherapy Moderna ASCO 2024 MRNA-4157
BRIEF published on 05/22/2024 at 13:05, 1 year 9 months ago Moderna annonce que les données seront présentées lors de l'assemblée annuelle 2024 de l'ASCO Immunothérapie Essais Cliniques Moderne ASCO 2024 ARNm-4157
PRESS RELEASE published on 05/22/2024 at 13:00, 1 year 9 months ago Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting Moderna to host an investor event via webcast on June 3 at 6:15 PM CDT. Abstracts on mRNA-4157 for ASCO Annual Meeting. Details on mRNA-4157 (V940) therapy development Webcast Moderna Investor Event MRNA-4157 Neoantigen Therapy
BRIEF published on 05/13/2024 at 13:05, 1 year 10 months ago Moderna Announces Participation in Key Investor Conferences Investor Conferences Healthcare Financial Markets Moderna Webcasts
BRIEF published on 05/13/2024 at 13:05, 1 year 10 months ago Moderna annonce sa participation à des conférences clés pour les investisseurs Marchés Financiers Soins De Santé Conférences Investisseurs Moderne Webdiffusions
PRESS RELEASE published on 05/13/2024 at 13:00, 1 year 10 months ago Moderna to Present at Upcoming Conferences in May/June 2024 Moderna, Inc. to participate in upcoming investor conferences, showcasing its leadership in mRNA medicine and innovative approach to disease treatment. Live webcasts available Investor Conferences Moderna Inc. MRNA Medicine Webcasts Disease Treatment
BRIEF published on 05/02/2024 at 12:35, 1 year 10 months ago Moderna Reports Q1 2024 Financial Performance and Strategic Progress Financial Results MRNA Technology Moderna RSV Vaccine Vaccine Development
Published on 03/19/2026 at 14:20, 6 hours 24 minutes ago CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report
Published on 03/19/2026 at 13:50, 6 hours 54 minutes ago Predictiv AI Appoints Multi-Agent Systems Pioneer Professor George Rzevski as Strategic Advisor to Advance Swarm AI Platforms
Published on 03/19/2026 at 13:30, 7 hours 14 minutes ago Hillcrest Energy Technologies CEO Don Currie Discusses ZVS Technology and Commercialization Progress in Stocks To Watch Investor Interview
Published on 03/19/2026 at 13:30, 7 hours 14 minutes ago ACCESS Newswire Reports Fourth Quarter and Full Year 2025 Results
Published on 03/19/2026 at 13:15, 7 hours 29 minutes ago Worksport Presents New Premium "Game Changer" Tonneau Cover Model to Industry Buyers at Keystone BIG Show; Initiates Pre-Orders Ahead of Near-Term Commercial Launch
Published on 03/19/2026 at 19:24, 1 hour 19 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/19/2026 at 18:26, 2 hours 17 minutes ago Malteries Franco Belges S.A.: Résultats du 1er semestre 2025/2026 et mise à disposition du rapport financier semestriel
Published on 03/19/2026 at 18:18, 2 hours 25 minutes ago VINCORION SE successfully completes Initial Public Offering
Published on 03/19/2026 at 18:00, 2 hours 44 minutes ago Filing of the 2025 Universal Registration Document
Published on 03/19/2026 at 18:00, 2 hours 44 minutes ago Mise à disposition du Document d’Enregistrement Universel 2025
Published on 03/19/2026 at 08:45, 11 hours 59 minutes ago Deezer et Sonos renouvellent et étendent leur partenariat stratégique
